Page last updated: 2024-10-26

ethosuximide and Aphasia

ethosuximide has been researched along with Aphasia in 1 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deuel, RK1
Lenn, NJ1

Other Studies

1 other study available for ethosuximide and Aphasia

ArticleYear
Treatment of acquired epileptic aphasia.
    The Journal of pediatrics, 1977, Volume: 90, Issue:6

    Topics: Aphasia; Child; Epilepsy; Ethosuximide; Female; Humans; Phenobarbital

1977